Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Saudi Arabia

 

Diaverum to IPO in Stockholm as Saudi JV buyout boosts EBITA

Global renal care group Diaverum's upcoming Stockholm IPO has 'strong international and Swedish investor interest', CEO Dimitris Moulavasilis tells HBI, as the market reaches historic highs. We talk expansion and diversification plans and 2020 performance. 
November 18, 2020

European operators brace for second wave

COVID's second wave looks either imminent, or is already starting to hit in many jurisdictions. Wave one saw lockdowns and closures - and not all closures were temporary. Will wave two be any different? HBI has been talking to operators across EMEA to see if forewarned is forearmed, how they predict the next few months will go, and what lessons have been learned.
October 1, 2020

Interview: Nasser Al Hagbani, CEO, Dr. Sulaiman Al Habib Medical Services Group

Saudi/UAE hospital operator Dr. Sulaiman Al Habib Medical Services Group (HmG) is by far the largest player by revenue in the GCC at $1.3bn. Shares have all but doubled since its IPO in March, making it the sixth-largest hospital stock globally by market capitalisation at $8.5bn. Its lucrative tele-ICU centre is the largest in the world by beds monitored. In this exclusive interview, Hagbani discusses HmG's listing, business model, Saudisation efforts, declining expat market and of course COVID-19.
September 2, 2020

GHP rolls out new deal with insurers

GHP, the Stockholm-listed Swedish and Middle East clinic chain, where shares have risen all but sevenfold in seven years, is rolling out a new outsourced model for health insurers. So far this covers 100,000 patients. We talk to CEO Daniel Ohman.
September 2, 2020

Interview: David Hadley, CEO, Mediclinic Middle East

EMEA hospital group Mediclinic International is undergoing its last substantial capital project in the UAE for the foreseeable future, Middle East CEO David Hadley tells HBI, as the group switches expansionary focus to neighbouring Saudi Arabia. We discuss the two markets and the reasons for the segment's recent $600m+ impairment charge.
August 6, 2020

Aster shows Covid impact on India and GCC

Thanks to Covid, Aster DM, the GCC to India clinic, hospital and pharmacy chain, saw a 25% drop in revenue across both geographies in April. May and June have seen improvements with a return to normal expected in the autumn, providing there is no second wave. We look in detail at the impact of Covid in March to June and report full year results to March 2020.
June 24, 2020

Labs bounce back and eye opportunities

A v-shaped recovery, new markets, new customers, new entrants, new technology and the ear of big government: the HBI 2020 diagnostics panel discussion reveals new opportunities.
June 11, 2020

€300m-plus IPO for Middle East’s largest imaging platform planned

Africa-focused private equity firm Meditterania Capital Partners intends to triple the EBITDA of its recently-formed imaging platform Ray Lab which spans Egypt, Jordan and Saudi Arabia before exiting, preferably by IPO, in a few years' time, partner Daniel Viñas tells HBI. He discusses the specifics of the deal, merging Ray Lab's two businesses, and how its markets are evolving.
June 11, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us